Janux Therapeutics Funding: $56M Raised, Series A (2021)
Janux Therapeutics is based in San Diego. It has raised $56M in total funding. Latest round: Series A.
Janux Therapeutics funding overview
Janux Therapeutics is based in San Diego. Janux Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Janux Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Avalon Ventures, OrbiMed, RA Capital Management, Bregua, Correlation Ventures. 5 distinct backers are named across the disclosed rounds.
Janux Therapeutics at a glance
Total raised
$56M
Latest round
Series A
Latest round date
March 2021
Headquarters
San Diego
Notable investors
Avalon Ventures, OrbiMed, RA Capital Management, Bregua, Correlation Ventures
Frequently asked about Janux Therapeutics funding
How much has Janux Therapeutics raised?
Janux Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Janux Therapeutics?
Avalon Ventures, OrbiMed, RA Capital Management, Bregua, Correlation Ventures are named among the investors backing Janux Therapeutics.
What was the latest Janux Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2021.
Where is Janux Therapeutics based?
Janux Therapeutics is based in San Diego.
When did Janux Therapeutics last raise?
The last disclosed Janux Therapeutics round closed in March 2021 at Series A.
We update the Janux Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.
